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ABSTRACT
Cranial metastasis from hepatocellular carcinoma (HCC) prior to diagnosis of the primary tumor without 
liver dysfunction is a very rare event. Cranial metastasis may be the sole initial presentation of HCC. Early 
diagnosis is essential in order to treat the primary disease. Cranial metastasis from HCC should be considered 
in the differential diagnosis in patients with subcutaneous scalp mass and osteolytic defects on X-ray.
A 55 year old female patient without known liver disease, presented with a palpable right occipital scalp 
mass. On head computed tomography (CT) scan, a tumor on right orbita wall, osteolytic skull and invasion to the 
right frontal lobe was observed. The histological diagnosis obtained from the biopsy was a poorly differentiated 
cranial metastasis adenocarcinoma that was difficult to determine the origin. On positron emission tomography 
(PET) scan, there was a hypermetabolic mass around intra hepatal bile duct which suspicious primary cancer. 
The histological diagnosis obtained from the liver biopsy was appropriate with HCC grade II. The metastatic 
tumor was removed via occipital craniectomy. She received a palliative course of external beam radiation 
therapy to the right orbit. Then, she received symptomatic treatment and herbal medicine with cassava leaves 
for the last three months. Evaluation of bone survey shows lytic lesion at calvaria and compression fracture 
at vertebrae thoracal 11-12 appropriate with metastasis process. According to Barcelona Clinic Liver Cancer 
(BCLC) criteria she suffered from HCC terminal stage D with average survival of about 4 months. 
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ABSTRAK
Metastasis kranial dari karsinoma hepatoselular sebelum diagnosis tumor primer dengan hasil tanpa adanya 
gangguan fungsi hati adalah peristiwa sangat jarang ditemui. Metastasis pada tulang kranial dapat menjadi 
salah satu presentasi awal dari karsinoma hepatoseluler. Menegakkan diagnosis di awal sangat diperlukan untuk 
menentukan penatalaksanaan pada penyakit primer. Metastasis pada kranial dari karsinoma hepatoseluler harus 
dipertimbangkan pada kasus subkutan skalp tumor dan pada pasien dengan defek osteolitik pada gambaran 
radiologi.
Seorang pasien perempuan usia 55 tahun, yang tidak didapatkan riwayat penyakit hati sebelumnya, datang 
dengan benjolan pada region oksipital kanan. Hasil computed tomography (CT) scan kepala didapatkan 
tumor pada dinding orbita kanan. Dari pemeriksaan histologi menunjukkan metastasis dari adenokarsinoma 
berdiferensiasi buruk yang sulit ditentukan asalnya. Pada pemeriksaan positron emission tomography (PET) 
scan, terdapat massa hipermetabolik di sekitar duktus intrahepatik yang diduga sebagai tumor primer. Hasil 
biopsi menunjukkan karsinoma hepatoselular derajat 2. Dilakukan kraniektomi region oksipital pada penyebaran 
tumor dan dilanjutkan radioterapi paliatif pada region oksipital kanan. Selanjutnya pasien hanya mendapatkan 
terapi simtomatik dan daun singkong sebagai terapi herbal selama 3 bulan terakhir. Evaluasi survei tulang 
setelah 3 bulan menunjukkan lesi litik pada kalvaria dan fraktur kompresi pada tulang vertebrae thorakal 11-
Volume 15, Number 1, April 2014 53
Cranial Metastasis as Initial Manifestation of Hepatocellular Carcinoma
12. Menurut kriteria Barcelona Clinic Liver Cancer (BCLC) pasien tersebut masuk ke dalam stadium terminal 
D dengan rata-rata angka harapan hidup 4 bulan setelah terdiagnosis.
Kata kunci: karsinoma hepatoseluler, metastasis kranial, terapi paliatif
INTRODUCTION
Hepatocellular carcinoma (HCC) is the fifth most 
common cancer in the world and is especially prevalent 
in African and East Asia.1 The higher incidence of 
HCC in Asia is related to the increased prevalence 
of chronic viral hepatitis B.2 Late stage HCC usually 
metastasizes to the regional lymph nodes and lungs, 
but less commonly to the skeleton.3 HCC usually 
metastasizes preferentially to the vertebral column, 
pelvis, and ribs, but rarely to the skull.4
Although the incidence of bone metastases in HCC 
has been described as very low in autopsy studies, an 
increasing trend has been reported. Because of the 
short survival of patients with HCC, their clinical 
presentations were mostly concerned with the 
manifestations of the primary cancer itself. However, 
recent progress in the treatment of HCC has made 
it possible for the patient to survive longer, and as a 
result distant metastasis from HCC including bone 
metastasis has increased and attracted more attention 
than before.4 In this report, we described a patient 
without previously known liver disease who presented 
with metastatic HCC of the skull before the diagnosis 
of a primary cancer.
CASE ILLUSTRATION
A 55 year old female patient presented with an 
incidentally found scalp mass four months prior to 
presentation. She did not have any history of recent 
head trauma or of any significant medical problems, 
including liver disease. She was known for having 
diabetes mellitus since seventeen years ago, took 
oral anti diabetic and insulin injection routinely. On 
admission, neurological and physical examination 
revealed no neurological deficits or hepatomegaly. A 
soft and non-movable mass about 1 × 2 cm over his 
occipital area was noted. The mass was slowly growing 
and caused occasional mild regional tenderness.
Laboratory tests demonstrated normal value of 
complete blood count, mild elevated liver function 
test, an alpha fetoprotein level of 14,893 ng/mL; 
carbohydrate antigen (CA) 19-9 386.28 U/mL and 
a negative serologic test for hepatitis C virus (HCV) 
antibody and hepatitis B virus antigen (HBsAg). 
Identifiable risk factors for HCC were found such as 
type 2 diabetes mellitus. Chest X-ray showed normal 
cor and pulmo.
Head computed tomography (CT) scan showed a 
highly enhanced extra conal lesion over right orbitae 
wall and enhanced right frontal lobe supra orbita 
which was concluded as a tumor on right orbita wall, 
osteolytic skull and invasion to the right frontal lobe 
hemangioma, meningioma, neurofibroma, sarcoma, 
pseudo-tumor (Figure 1). The first percutaneous 
needle biopsy showed group of hypercellular, 
pleomorphic, hyperchromatic, oval nucleus, bluish 
cytoplasm forming acinus with necrotic debris and 
eosinophilic matrix background which was concluded 
as adenocarcinoma.
Figure 1. Head CT scan focusing on orbitae showed tumor 
on right orbita wall, osteolytic skull and invasion to the right 
frontal lobe (arrow sign)
Under general anesthesia, the tumor was radically 
resected along with surrounding normal bone via 
craniotomy. During surgery, a grossly well demarcated 
reddish brown mass (reflecting its high vascularity) 
penetrated both tables of the skull through the diploic 
space. The underlying duramater was intact and did 
not show evidence of gross tumor invasion. The 
second biopsy from frontal lobe of cerebri showeds 
tumor cranial metastasis adenocarcinoma poorly 
differentiated that difficult to determine the origin.
 Multi slice CT (MSCT) scan post craniotomy 
showed solid extra axial heterogen mass in right frontal 
intracranial extend pass through os frontal, part of right 
sinus frontal, narrowing peripheral cortical sulci right 
frontal, without vasogenic edema. Right extraconal 
retroorbital space extend pass through orbital roff 
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destruction, with shuffled right bulbus oculi and right 
orbita superior musculus rectus to inferior (Figure 2).
Figure 2. Multi slice head CT scan showed solid extra-axial 
heterogenic mass in right frontal
Retrograde diagnostic work up for detecting the 
primary cancer was performed. A positron emission 
tomography (PET) scan performed 65 minutes after 
Fluor-18 fluorodeoxyglucose (FDG) from head to 
toe; attenuated correction was performed with low 
dose CT non-contrast. Quantitative measurements 
were performed with standardize uptake value (SUV). 
Impression of a hypermetabolic mass around intra 
hepatal bile duct which was suspected to be the primary 
cancer (probably a cholangiocarcinoma). Hyperdense 
lesion with high metabolic activity in right frontal 
region with right frontal sinus destruction and medial 
wall right os orbitae with right frontal bone defect 
in anterior, suggesting metastasis process (Figure 
3). Hypermetabolic lesion in pancreaticoduodenale 
lymphnode and lytic lesion left posterior os parietal 
suggesting metastasis process, lobulated multiple 
nodules in right lobe of thyroid which were very large 
size and metabolic activity, inhomogen density and 
multiple calcification.
Confirmed with liver biopsy showed billiary 
obstruction in liver tissue, fibrosis portal with bile 
duct proliferation, Tumor mass content of polygonal 
cells stack on solid and trabecular form, spherical/
oval nucleus, hyperchromatic, eosinophilic cytoplasm, 
conclusion suggestive of hepatocellular cell carcinoma 
grade II. 
Figure 4. Positron emission tomography scan showed 
suspected primary cancer (cholangiocarcinoma), lesion with 
high metabolic activity in right frontal region suggestive 
metastasis process (red sign)
Figure 5. Abdominal ultrasonography showed multilobulated 
mass in homogen hyperechoic in right lobe of liver (arrow sign)
Figure 3. PET scan showed a). hyperdense lesion with high 
metabolic activity in right frontal region; b) hypermetabolic 
mass around intra hepatal bile duct
a b
An abdominal sonogram identified after she 
underwent liver biopsy, with impressions of slightly 
hepatomegaly in right lobe, coarse liver texture 
multilobulated lobuler inhomogen right lobe liver 
around billiary tract, showed unclear border with 
diameter 3-6 cm. Close with mass area, there was 
spheric zone hyperechoic, clear borderline, diameter 
4 x 4.5 cm. Widening right intrahepatal billiary tract, 
right portal vein not clearly demarcated, without 
ascites, suggestive malignant neoplasm with post 
biopsy hematoma (Figure 5).
The patient received a palliative course of external 
beam radiation therapy to the right orbit. Intensity 
modulated radiation therapy (IMRT) was used to allow 
sparing of critical normal tissues in close proximity 
to the tumor. Two months after completion of IMRT 
to 58 Gray in 30 fractions delivered over 10 week, 
the patient had a complete clinical and symptomatic 
response. The patient was followed up in the outpatient 
gastroentero-hepatology clinic.
 After 3 months, hepatic dysfunction due to the 
progression of primary cancer and evidence of the 
recurrence of skull metastasis were observed. She got 
cassava herbals medicine since the last two months. 
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Her abdominal USG after 1 month of therapy showeds 
solid mass in right liver lobe, with impressions 
increased size of mass and showeds peripancreatic 
lymphadenopathy.
The bone survey showed lytic lesion at calvaria 
(Figure 6), compression fracture of vertebrae thoracal 
11-12 appropriate with metastasis process, spondylosis 
lumbalis and osteoporosis (Figure 7). She received an 
opioid analgetics and continued the herbal medicine.
In spite of the low incidence of skull metastases, 
there have been interesting trends in the reports about 
skull metastases from HCC. Moreover, in comparison 
with the incidence of skull metastases before the 
1980's, the incidence after the 1990's has clearly 
increased because of a prolonged survival rate due 
to recent progress in the diagnosis and treatment of 
HCC.4,7 Therefore, particularly in Asia, patients with 
HCC should be closely monitored for skull metastases. 
Plain skull X-ray is the most frequent initial diagnostic 
step in the patient with clinical suspicion of a bone 
lesion, while bone scan with technetium-99-methylene 
diphosphonate is widely used as a screening tool to 
detect bone metastases. On radiological examination, 
osteolytic type behavior with a tendency to be highly 
enhanced is the most common finding.6,7 However 
these findings are not specific to only HCC: most 
skull metastases appear as osteolytic, expansile, 
and hypervascular lesions.10 Metastases are the 
most common cranial neoplasms in adults, of which 
60% are from breast and lung carcinoma, although 
hematogenous skull metastases can be caused by nearly 
all types of tumors.11
Because of the wide spectrum of primary cancers 
causing skull metastases, and because of their 
indistinguishable radiological findings, pathological 
confirmation by biopsy is required. Our case also 
required a biopsy for histopathological confirmation of 
the skull tumor. Metastases from HCC seldom emerge 
as an initia diagnosis of a solitary skull tumor, because 
skull metastasis from HCC prior to diagnosis of the 
primary cancer is very rare.7 Moreover, our patient 
had a mildly elevated liver function test and was 
asymptomatic from her primary liver cancer. A solitary 
skull metastasis from HCC is very rare, but this type 
of metastases could be explained by the osseous route 
of HCC metastasis.
Metastases in the central nervous system from 
HCC generally occur through two different kinds of 
pathways in the advanced stage of HCC.6,7 One of them 
is the hematogenous route via the lung to the brain 
parenchyma without skull involvement. In this group, 
the character of HCC is defined as a "neutrophilic" 
cancer, and the lung is the most common site of 
extracranial metastases. On the other hand, the second 
route is the osseous route via Batson's venous plexus to 
the skull. In this group, bone is the most common site 
of extracranial metastases, and HCC is characterized as 
an "osteophilic" cancer. Cancer cells might disseminate 
within the dipole via the diploic venous channels and 
expand through the inner and outer table of the skull.7 
DISCUSSION 
The incidence of skeletal metastasis from HCC is 
estimated to be 2–16%, depending on the prevalence 
of the primary disease in the population.4,6 The most 
frequent sites of osseous metastases from HCC are 
vertebrae, the sternum, ribs, and long bones, with the 
incidence in the skull is low at 0.5%–1.6%.1,7-9 Skull 
metastases from HCC predominantly affect males in 
their sixth and seventh decades, with similar age and 
sex distributions to those with only HCC.9
Figure 6. Skull rontgen showed lytic lesion in calvaria
Figure 7. Thoracolumbal antero-posterior/lateral shows fracture 
compression at V thoracal XI-XII
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Therefore, it is difficult to find the skull metastasis from 
HCC without the presence of other bone metastases.
This patient initially visited the hospital due to the 
incidentally discovered scalp mass. In the literature, 
a subcutaneous mass with occasional pain is the most 
common clinical presentation (63%), followed by 
neurological deficits (44%), headache (11%), and 
seizure.1 The neurological deficits, such as facial 
palsy, deafness, visual disturbance, facial numbness, 
weakness of limbs, and other cranial nerve palsies, 
are associated with the tumor size and location. 
Neurological deficits are more frequently present in 
metastases of the skull base rather than the cranial 
vault.1,10
Several treatment options can be used to treat the 
skull metastases from HCC, including direct ethanol 
injection therapy, radiotherapy, surgical resection, 
herbal medicine, stem cell therapy and supportive 
management. Many previous reports suggested that 
most patients with skull metastases died due to liver 
failure and that surgical resection of the metastatic 
lesion could not prolong survival.1,4,10 The stage of the 
primary cancer is mostly associated with the prognosis. 
However, surgical resection of the skull metastases is 
acceptable for preventing intracranial hemorrhage and 
neurological deterioration. Surgical intervention also 
allows biopsy, whereby the tumor can be histologically 
confirmed; such biopsies are easier to perform in 
cranial vault-sited cases.1,3,12
The present study examined apoptotic inducing 
mechanisms in the natural killer (NK) cell cytotoxic 
activity pathway to determine an additional 
measurement for NK cell effector function. The results 
showed that perforin was significantly correlated 
with cytotoxic activity and degranulation, indicating 
that it may be an additional measurement for NK cell 
cytotoxic activity.
The correlation of perforin release with the lysis 
of tumour cells and degranulation suggests that 
perforin may be an additional measurement for NK 
cell effector function. As perforin is a lytic protein 
released from NK cells to induce apoptosis in the target 
cell, measurement of perforin may be beneficial in the 
clinical setting for identifying deficiencies affecting 
cytotoxic activity.
Although a solitary skull metastasis prior to the 
diagnosis of HCC demonstrates rare metastatic 
behavior for HCC, especially in Asia, skull metastases 
from HCC should be included in the differential 
diagnosis of skull tumors, even if the patient is 
asymptomatic of liver cirrhosis. With the increase 
survival of HCC patients, clinically significant bone 
metastases have also increased, affecting the patients' 
quality of life. Therefore, early diagnosis and proper 
management of bone metastasis from HCC is essential 
to prevent deterioration in the quality of life of HCC 
patients.
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